Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.69 (
BMT
)
2,655
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Apolipoprotein (apo)E is synthesized in atherosclerotic lesions by macrophages, however, its role in lesions is not known. Whereas
apoE
could exacerbate atherosclerosis by promoting macrophage uptake of cholesterol-rich lipoproteins or modulating protective inflammatory responses, it could also restrict lesion formation by facilitating cholesterol efflux out of lesions. The role of
apoE
was examined in lethally irradiated male C57BL/6J wild-type (WT) mice that were repopulated with bone marrow cells (
BMT
) from either identical C57BL/6J mice (WT+WT
BMT
) or C57BL/6J
apoE
-deficient mice (WT+E-/-
BMT
). This enabled us to compare normal mice with mice possessing macrophages that did not express
apoE
. The participation of macrophage-derived
apoE
in atherosclerosis was assessed by placing the mice on an atherogenic diet. Male WT+E-/-
BMT
mice had significantly reduced lesion area in the aortic valves (P < 0.01) compared with male WT+WT
BMT
mice ( approximately 22,000 vs. approximately 49,000 microm2/section, respectively). Further evaluation revealed that plasma cholesterol, lipoprotein cholesterol distribution, and plasma
apoE
were similar between the two groups, indicating that these known risk factors did not account for the differences in lesion area. However, the two groups were distinguished by the amount of
apoE
found in the lesions. ApoE antigen was expressed abundantly in WT+WT
BMT
lesions, whereas WT+E-/-
BMT
lesions contained little
apoE
. These findings indicate that the majority of
apoE
in lesions is synthesized locally by resident macrophages, and suggest that locally produced
apoE
can promote diet-induced atherosclerosis in male wild-type mice.
...
PMID:Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice. 1022 49